GlassScriptPhysician profile
Yaochung Weng
NPI 1205299344
$3,634.82
in general payments reported to CMS, 2019-2025
51 companies · $1,097 in 2025
The $1,097 reported for 2025 was more than what 84% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $126 · 2022: $286 · 2023: $971 · 2024: $1,155 · 2025: $1,097.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,223.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $613.50 | 2022-2025 | Enhertu, Injectafer, Datroway |
| Novartis Pharmaceuticals Corporation | $380.66 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $362.61 | 2023-2025 | Keytruda, Lynparza, Welireg |
| Dendreon Pharmaceuticals LLC | $127.76 | 2024-2025 | Provenge |
| Novocure INC. | $125.77 | 2021 | |
| Pfizer INC. | $123.30 | 2022-2025 | |
| Glaxosmithkline, LLC. | $90.09 | 2022-2025 | Jemperli |
| Janssen Biotech, INC. | $89.61 | 2024-2025 | Tecvayli, Talvey, Darzalex |
| Incyte Corporation | $79.29 | 2023-2025 | Monjuvi, Jakafi |
| Eisai INC. | $76.13 | 2023-2025 | |
| Sobi, INC | $72.15 | 2024-2025 | |
| Blueprint Medicines Corporation | $71.58 | 2024-2025 | Ayvakit |
| Genzyme Corporation | $65.73 | 2024-2025 | |
| Blue Earth Diagnostics | $65.18 | 2024-2025 | Posluma |
| Astrazeneca Pharmaceuticals LP | $64.72 | 2024-2025 | Lynparza, Imfinzi |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $64.17 | 2024-2025 | Trelstar, Tlando |
| Jazz Pharmaceuticals INC. | $61.29 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $60.89 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $60.48 | 2024 | Fruzaqla, Iclusig |
| Regeneron Healthcare Solutions, INC. | $55.81 | 2024-2025 | Libtayo |
| Karyopharm Therapeutics INC. | $51.98 | 2024-2025 | Xpovio |
| Adc Therapeutics America, INC. | $49.12 | 2024-2025 | |
| Lilly USA, LLC | $45.45 | 2023-2024 | Verzenio, Jaypirca |
| Amgen INC. | $45.36 | 2023 | Lumakras |
| Stemline Therapeutics INC. | $44.57 | 2024-2025 | Orserdu |
| Shield Therapeutics INC | $43.26 | 2024 | |
| Acrotech Biopharma INC. | $40.52 | 2023 | Beleodaq |
| Sirtex Medical INC | $39.56 | 2025 | Sir-Spheres Microspheres |
| Seagen INC. | $38.97 | 2023 | Adcetris |
| Tactile Systems Technology INC | $38.95 | 2024 | Entre Plus, Flexitouch Plus |
| Pharmacosmos Therapeutics INC. | $35.18 | 2025 | Monoferric |
| Tersera Therapeutics LLC | $31.36 | 2025 | Zoladex, Quzyttir |
| Icotec Medical INC. | $30.32 | 2025 | Kong-Tl Vbr, End Plate, Round, L and Screw, 12 X 43 Mm, Kong-Tl Vbr, End Plate, Rectangular, M and Screw, 12 X 33 Mm, Kong-Tl Vbr E, Expandable Body, L, 19 Mm X 27 - 37 Mm |
| Mirati Therapeutics, INC. | $28.13 | 2023 | Krazati |
| Aveo Pharmaceuticals, INC. | $25.90 | 2025 | |
| Astellas Pharma US INC | $24.92 | 2025 | Padcev |
| Beone Medicines USA, INC. | $24.89 | 2025 | Brukinsa |
| Sun Pharmaceutical Industries INC. | $24.88 | 2023 | Odomzo, Yonsa |
| Agios Pharmaceuticals, INC. | $24.01 | 2023 | Pyrukynd |
| Rigel Pharmaceuticals, INC. | $22.49 | 2025 | Tavalisse, Rezlidhia, Gavreto |
| Kyowa Kirin, INC. | $22.23 | 2024 | Poteligeo |
| Genmab U.S., INC. | $21.11 | 2023 | Tivdak |
| Genentech USA, INC. | $20.64 | 2023 | Venclexta |
| Adaptive Biotechnologies Corporation | $19.97 | 2025 | Clonoseq |
| Elucent Medical | $19.86 | 2025 | |
| Recordati_rare_diseases_inc. | $19.77 | 2025 | Sylvant |
| Puma Biotechnology, INC. | $19.76 | 2022 | |
| Iovance Biotherapeutics, INC. | $19.08 | 2025 | Amtagvi |
| Secura Bio, INC. | $18.14 | 2023 | Copiktra |
| Progenics Pharmaceuticals, INC. | $16.97 | 2023 | Pylarify |
| Spectrum Pharmaceuticals INC. | $16.75 | 2024 | Rolvedon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yaochung Weng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.